Zusammenfassung
Weichgewebesarkome sind seltene Erkrankungen. Unabhängig von der Lokalisation ist die Chirurgie die wichtigste Behandlungsmethode der nicht metastasierten Erkrankung. Fortschritte in der onkologischen und rekonstruktiven Chirurgie haben gemeinsam mit dem Einsatz multimodaler Therapien stark funktionseinschränkende Operationen bei Extremitätensarkomen zu seltenen Eingriffen gemacht. Eine besondere Rolle spielt dabei das Verständnis für eine fokale marginale Resektion im multimodalen Behandlungskonzept. Bei retroperitonealen Sarkomen ist ein Lokalrezidiv lebensbedrohlich und die gezielte Mitresektion angrenzender Organe im Sinne einer Multiviszeralresektion hat sich als Standardoperation durchgesetzt. In diesem Artikel werden neben der chirurgischen Diagnostik und Therapieplanung die Operationsstrategie von Weichgewebesarkomen der Extremitäten und des Retroperitoneums diskutiert.
Abstract
Soft-tissue sarcomas are rare malignant tumors. Surgery remains the most important treatment modality. Neoadjuvant and/or adjuvant chemo- and radiotherapy may be administered to improve the local and systemic outcome. Advances in oncological and reconstructive surgery, combined with the use of multimodal therapies, have made mutilating surgery rare events in extremity sarcomas. In retroperitoneal sarcomas, local recurrences are life-threatening events and multivisceral resection has become the standard surgical procedure. The subjects of this review are diagnostics, multimodal therapy, and resection strategy from a surgical point of view.
Literatur
Berger-Richardson D, Swallow CJ (2017) Needle tract seeding after percutaneous biopsy of sarcoma: Risk/benefit considerations. Cancer 123:560–567
Blay JY, Soibinet P, Penel N et al (2017) Improved survival using specialized multidisciplinary board in sarcoma patients. Ann Oncol 28:2852–2859
Bonvalot S, Raut CP, Pollock RE et al (2012) Technical considerations in surgery for retroperitoneal sarcomas: Position paper from E‑Surge, a master class in sarcoma surgery, and EORTC-STBSG. Ann Surg Oncol 19:2981–2991
Callegaro D, Miceli R, Bonvalot S et al (2016) Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: A retrospective analysis. Lancet Oncol 17:671–680
Casali PG, Abecassis N, Bauer S et al (2018) Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29:iv51–iv67
Chhabra A, Ashikyan O, Slepicka C et al (2018) Conventional MR and diffusion-weighted imaging of musculoskeletal soft tissue malignancy: Correlation with histologic grading. Eur Radiol. https://doi.org/10.1007/s00330-018-5845-9
De La La Hoz Polo M, Dick E, Bhumbra R et al (2017) Surgical considerations when reporting MRI studies of soft tissue sarcoma of the limbs. Skeletal Radiol 46:1667–1678
Fairweather M, Wang J, Jo VY et al (2018) Surgical management of primary retroperitoneal sarcomas: Rationale for selective organ resection. Ann Surg Oncol 25:98–106
Grabellus F, Podleska LE, Sheu SY et al (2013) Neoadjuvant treatment improves capsular integrity and the width of the fibrous capsule of high-grade soft-tissue sarcomas. Eur J Surg Oncol 39:61–67
Gronchi A, Ferrari S, Quagliuolo V et al (2017) Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): An international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol 18:812–822
Gronchi A, Lo Vullo S, Fiore M et al (2009) Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol 27:24–30
Gronchi A, Strauss DC, Miceli R et al (2016) Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): A report on 1007 patients from the multi-institutional collaborative RPS working group. Ann Surg 263:1002–1009
Gundle KR, Kafchinski L, Gupta S et al (2018) Analysis of margin classification systems for assessing the risk of local recurrence after soft tissue sarcoma resection. J Clin Oncol 36:704–709
Haas RL, Delaney TF, O’sullivan B et al (2012) Radiotherapy for management of extremity soft tissue sarcomas: Why, when, and where? Int J Radiat Oncol Biol Phys 84:572–580
Harati K, Goertz O, Pieper A et al (2017) Soft tissue sarcomas of the extremities: Surgical margins Can be close as long as the Resected tumor has no ink on it. Oncologist 22:1400–1410
Jakob J, Gerres A, Ronellenfitsch U et al (2018) Treatment of retroperitoneal sarcoma in Germany : Results of a survey of the German Society of General and Visceral Surgery, the German Interdisciplinary Sarcoma Study Group and the advocacy group Das Lebenshaus. Chirurg 89:50–55
Jakob J, Hohenberger P (2016) Role of isolated limb perfusion with recombinant human tumor necrosis factor alpha and melphalan in locally advanced extremity soft tissue sarcoma. Cancer 122:2624–2632
Kainhofer V, Smolle MA, Szkandera J et al (2016) The width of resection margins influences local recurrence in soft tissue sarcoma patients. Eur J Surg Oncol 42:899–906
Lansu J, Groenewegen J, Van Coevorden F et al (2019) Time dependent dynamics of wound complications after preoperative radiotherapy in extremity soft tissue sarcomas. Eur J Surg Oncol. https://doi.org/10.1016/j.ejso.2018.09.001
Mohr Z, Hirche C, Klein T et al (2012) Vacuum-assisted minimally invasive biopsy of soft-tissue tumors. J Bone Joint Surg Am 94:103–109
O’sullivan B, Davis AM, Turcotte R et al (2002) Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: A randomised trial. Lancet 359:2235–2241
Pasquali S, Pizzamiglio S, Touati N et al (2019) The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial. Eur J Cancer 109:51–60
Pencavel TD, Strauss DC, Thomas GP et al (2010) Does the two-week rule pathway improve the diagnosis of soft tissue sarcoma? A retrospective review of referral patterns and outcomes over five years in a regional sarcoma centre. Ann R Coll Surg Engl 92:417–421
Perrier L, Buja A, Mastrangelo G et al (2012) Clinicians’ adherence versus non adherence to practice guidelines in the management of patients with sarcoma: A cost-effectiveness assessment in two European regions. BMC Health Serv Res 12:82
Pohlig F, Kirchhoff C, Lenze U et al (2012) Percutaneous core needle biopsy versus open biopsy in diagnostics of bone and soft tissue sarcoma: A retrospective study. Eur J Med Res 17:29
Qureshi YA, Huddy JR, Miller JD et al (2012) Unplanned excision of soft tissue sarcoma results in increased rates of local recurrence despite full further oncological treatment. Ann Surg Oncol 19:871–877
Ressing M, Wardelmann E, Hohenberger P et al (2018) Strengthening health data on a rare and heterogeneous disease: Sarcoma incidence and histological subtypes in Germany. BMC Public Health 18:235
Smolle MA, Leithner A, Grimer RJ (2015) Evaluating the British sarcoma referral form. Ann R Coll Surg Engl 97:434–438
Strauss DC, Qureshi YA, Hayes AJ et al (2010) The role of core needle biopsy in the diagnosis of suspected soft tissue tumours. J Surg Oncol 102:523–529
Townley WA, Mah E, O’neill AC et al (2013) Reconstruction of sarcoma defects following pre-operative radiation: Free tissue transfer is safe and reliable. J Plast Reconstr Aesthet Surg 66:1575–1579
Traub F, Griffin AM, Wunder JS et al (2018) Influence of unplanned excisions on the outcomes of patients with stage III extremity soft-tissue sarcoma. Cancer 124:3868–3875
Van Houdt WJ, Schrijver AM, Cohen-Hallaleh RB et al (2017) Needle tract seeding following core biopsies in retroperitoneal sarcoma. Eur J Surg Oncol 43:1740–1745
Von Mehren M, Randall RL, Benjamin RS et al (2018) Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 16:536–563
Woll PJ, Reichardt P, Le Cesne A et al (2012) Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): A multicentre randomised controlled trial. Lancet Oncol 13:1045–1054
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
J. Jakob und P. Hohenberger geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
Schwerpunktherausgeber
M. Evert, Regensburg
Rights and permissions
About this article
Cite this article
Jakob, J., Hohenberger, P. Prinzipien der Sarkomchirurgie. Pathologe 40, 431–435 (2019). https://doi.org/10.1007/s00292-019-0631-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00292-019-0631-2